Chemical Compound

3-Isoquinolinamine, N-[2-[(3S,4R)-3-fluoro-4-methoxy-1-piperidinyl]-4-pyrimidinyl]-5-(1-methylethyl)-8-[(2R,3S)-2-methyl-3- [(methylsulfonyl)methyl]-1-azetidinyl]-

CAS Registry Number 2660250-10-0
3-Isoquinolinamine, N-[2-[(3S,4R)-3-fluoro-4-methoxy-1-piperidinyl]-4-pyrimidinyl]-5-(1-methylethyl)-8-[(2R,3S)-2-methyl-3- [(methylsulfonyl)methyl]-1-azetidinyl]- 结构式
Primary record

3-Isoquinolinamine, N-[2-[(3S,4R)-3-fluoro-4-methoxy-1-piperidinyl]-4-pyrimidinyl]-5-(1-methylethyl)-8-[(2R,3S)-2-methyl-3- [(methylsulfonyl)methyl]-1-azetidinyl]-

库存
9,197 克
纯度
99.7 %
CAS
2660250-10-0

化合物标识与属性

CAS
2660250-10-0
PubChem CID
156538665
SMILES
C[C@@H]1[C@H](CN1C2=C3C=NC(=CC3=C(C=C2)C(C)C)NC4=NC(=NC=C4)N5CC[C@H]([C@H](C5)F)OC)CS(=O)(=O)C
Canonical SMILES
CO[C@@H]1CCN(c2nccc(Nc3cc4c(C(C)C)ccc(N5C[C@H](CS(C)(=O)=O)[C@H]5C)c4cn3)n2)C[C@@H]1F

名称与同义词

  • BLU-945
  • Tigozertinib
  • BLU945
  • PA4PTH5HL9
  • 2660250-10-0
  • tigozertinib [INN]
  • Tigozertinib (USAN)
  • UNII-PA4PTH5HL9
  • RefChem:1100118
  • TIGOZERTINIB [USAN]
  • BLU 945
  • EGFR Inhibitor BLU-945
  • C28H37FN6O3S
  • orb1685231
  • Egfr mutant-selective inhibitor BLU-945
  • BLU 945 [WHO-DD]
  • CHEMBL5095169
  • SCHEMBL23579296
  • SCHEMBL29412933
  • SCHEMBL29861760
  • GTPL11948
  • WLZ3535
  • GLXC-25704
  • BLU-945?
  • EX-A6018
  • BDBM50598686
  • EO2401
  • AKOS040759965
  • EBC-221102
  • MS-30145
  • SY311008
  • Compound 150 [WO2021133809A1]
  • HY-144680
  • CS-0433912
  • D12730
  • F78343
  • A946503
  • N-[2-[(3S,4R)-3-fluoro-4-methoxypiperidin-1-yl]pyrimidin-4-yl]-8-[(2R,3S)-2-methyl-3-(methylsulfonylmethyl)azetidin-1-yl]-5-propan-2-ylisoquinolin-3-amine
  • 3-Isoquinolinamine, N-(2-((3S,4R)-3-fluoro-4-methoxy-1-piperidinyl)-4-pyrimidinyl)-5-(1-methylethyl)-8-((2R,3S)-2-methyl-3-((methylsulfonyl)methyl)-1-azetidinyl)-
  • N-(2-((3S,4R)-3-Fluoro-4-methoxypiperidin-1-yl)pyrimidin-4-yl)-5-isopropyl-8-((2R,3S)-2-methyl-3-((methylsulfonyl)methyl)azetidin-1-yl)isoquinolin-3-amine
  • N-[2-[(3S,4R)-3-Fluoro-4-methoxy-1-piperidyl]-4-pyrimidinyl]-5-isopropyl-8-[(2R,3S)-2-methyl-3-[(methylsulfonyl)methyl]-1-azetidinyl]isoquinolin-3-amine
  • 3-Isoquinolinamine, N-[2-[(3S,4R)-3-fluoro-4-methoxy-1-piperidinyl]-4-pyrimidinyl]-5-(1-methylethyl)-8-[(2R,3S)-2-methyl-3- [(methylsulfonyl)methyl]-1-azetidinyl]-
  • N-(2-((3S,4R)-3-fluoro-4-methoxypiperidin-1-yl)pyrimidin-4-yl)-8-((2R,3S)-2-methyl-3-(methylsulfonylmethyl)azetidin-1-yl)-5-propan-2-ylisoquinolin-3-amine
  • N-[2-[(3S,4R)-3-Fluoro-4-methoxy-1-piperidinyl]-4-pyrimidinyl]-5-(1-methylethyl)-8-[(2R,3S)-2-methyl-3-[(methylsulfonyl)methyl]-1-azetidinyl]-3-isoquinolinamine
  • N-[2-[(3S,4R)-3-fluoro-4-methoxy-1-piperidyl]pyrimidin-4-yl]-5-isopropyl-8-[(2R,3S)-2-methyl-3-(methylsulfonylmethyl)azetidin-1-yl]isoquinolin-3-amine
  • N-{2-[(3S,4R)-3-fluoro-4-methoxypiperidin-1-yl]pyrimidin-4-yl}-5-(propan-2-yl)-8-[(2R,3S)-2-methyl-3-[(methanesulfonyl)methyl]azetidin-1-yl]isoquinolin-3-amine
  • N-{2-[(3S,4R)-3-fluoro-4-methoxypiperidin-1-yl]pyrimidin-4-yl}-8-{(2R,3S)-3-[(methanesulfonyl)methyl]-2-methylazetidin-1-yl}-5-(propan-2-yl)isoquinolin-3-amine
  • N/A